< />
FDA Logo--links to FDA home page
U.S. Food and Drug Administration
HHS Log--links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA


horizontal rule

Grants Awarded by the OOPD Grant Program

This list contains all currently funded grants.
To search for one in particular, please use the Find option of your Web browser (generally this is found under the Edit menu).

 



Title: Hydroxychloroquine vs. Phlebotomy for Porphyria cutanea tarda (PCT)
Principal Investigator: Dr. Karl Anderson
Institution: University of Texas Medical Branch
City / State: Galveston, TX


Title: Effect of Diflunisal on Familial Amyloidosis
Principal Investigator: John Berk
Institution: Boston University Medical Campus


City / State: Boston, MA
Title: Treatment of Hypoparathyroidism with Parathyroid Hormone
Principal Investigator: Dr. John Bilezikian
Institution: Columbia University Health Sciences


City / State: New York, NY
Title: Cultured Skin Substitutes for Closure of Burn Wounds
Principal Investigator: Dr. Steven Boyce
Institution: University of Cincinnati
City / State: Cincinnati, OH


Title: Phase III Study of Tetrathiomolybdate Dose Regimen in Neurological Wilson's Disease
Principal Investigator: Dr. George Brewer
Institution: Univeristy of Michigan
City / State: Ann Arbor, MI


Title: Phase III Trial of Tetrathiomolybdate in Primary Biliary Cirrhosis
Principal Investigator: Dr. George Brewer
Institution: The Regents of the University of Michigan
City / State: Ann Arbor, MI


Title: Phase III Trial of Tetrathiomolybdate in Initial Hepatic Wilson's Disease
Principal Investigator: Dr. George Brewer
Institution: University of Michigan
City / State: Ann Arbor, MI



Title: Triptorelin for Ovary Protection in Childhood Lupus
Principal Investigator: Dr. Hermine Brunner
Institution: Cincinnati Children's Hospital Medical Center
City / State: Cincinnati, OH


Title: Phase II Randomized Trial Of IVIG With Or Without Cyclophosphamide In Pemphigus
Principal Investigator: Dr. Jean-Claude Bystryn
Institution: New York University School of Medicine
City / State: New York, NY


Title: Phase II Trial of Moxifloxacin for TB
Principal Investigator: Dr. Richard Chaisson
Institution: Johns Hopkins University
City / State: Baltimore, MD


Title: Phase I/II Study of Nelfinavir in Liposarcoma
Principal Investigator: Dr. Warren Chow
Institution: Beckman Research Institute of City of Hope
City / State: Duarte, CA


Title: Giant Cell Myocarditis Treatment Trial Pilot Study
Principal Investigator: Dr. Leslie Cooper
Institution: Mayo Clinic Rochester
City / State: Rochester, MN


Title: Phase II Trial to Study Thymosin Beta 4 (Tb4) in Epidermolysis Bullosa
Principal Investigator: Mr. David Crockford
Institution: RegeneRx Biopharmaceuticals Inc
City / State: Bethesda, MD


Title: Microsomal Triglyceride Transfer Protein(MTP)Inhibitor in Familial Hypercholesterolemia
Principal Investigator: Dr. Marina Cuchel
Institution: University of Pennsylvania
City / State: Philadelphia , PA


Title: Double Blind Study of Minocycline in Huntington's Disease (HD)
Principal Investigator: Merit Cudkowicz
Institution: Massachusetts General Hospital
City / State: Boston, MA



Title: Phase II Trial of Ontak to Treat Ovarian Cancer
Principal Investigator: Dr. Tyler Curiel
Institution: Tulane University Health Sciences Center
City / State: New Orleans, LA


Title: DC-Tumor Conjugate Vaccine for the Immunotherapy of CTCL
Principal Investigator: Dr. Louis Falo, Jr.
Institution: University of Pittsburgh
City / State: Pittsburgh, PA


Title: Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
Principal Investigator: Dr. Abhimanyu Garg
Institution: Univ. or Texas Southwestern Medical Center
City / State: Dallas, TX


Title: Growth Hormone Use in Pseudohypoparathyroidism Type 1A
Principal Investigator: Emily Germain-Lee
Institution: Johns Hopkins University
City / State: Baltimore, MD


Title: Phase 1 Clinical Trial Using Rexin-G for Pancreatic Cancer
Principal Investigator: Dr. Frederick Hall
Institution: Epeius Biotechnologies Corp.
City / State: Monrovia, CA


Title: Intraventricular Hemmorrhage Thrombolysis Trial
Principal Investigator: Dr. Daniel Hanley
Institution: The Johns Hopkins University
City / State: Baltimore, MD


Title: Rosiglitazone: Novel Therapy for Pituitary Tumors Phase II
Principal Investigator: Dr. Anthony Heaney
Institution: Cedars-Sinai Medical Center
City / State: Los Angeles, CA


Title: PEG-Uricase as Therapy for Refractory Gout
Principal Investigator: Dr. Michael Hershfield
Institution: Duke University
City / State: Durham, NC



Title: Phase II Study of Rapamycin in Pancreatic Cancer
Principal Investigator: Dr. Manuel Hidalgo
Institution: Johns Hopkins University
City / State: Baltimore, MD


Title: High Dose (DHA )and X-Linked Retinitis Pigmentosa: Phase II
Principal Investigator: Dr. Dennis Hoffman
Institution: Retina Foundation of the Southwest
City / State: Dallas, TX


Title: Fluoxetine in Pediatric Body Dysmorphic Disorder
Principal Investigator: Dr. Eric Hollander
Institution: Mount Sinai School of Medicine
City / State: New York, NY


Title: Anti-CEA Designer T Cells in Gastric Cancer: Phase I
Principal Investigator: Richard Junghans
Institution: Roger Williams Hospital
City / State: Providence, RI


Title: Phase II Study of Alendronate in Juvenile Osteoporosis
Principal Investigator: Dr. Lyndon Key
Institution: Medical University of South Carolina
City / State: Charleston, SC


Title: MND-ADA Transduced CD34+ Cells for ADA-SCID
Principal Investigator: Dr. Donald Kohn
Institution: Children's Hospital Los Angeles
City / State: Los Angeles, CA


Title: 131-I 3F8 for Leptomeningeal Cancers
Principal Investigator: Dr. Kim Kramer
Institution: Sloan-kettering Institute for Cancer Research
City / State: New York, NY


Title: Topical Dehydrex in treating Recurrent Corneal Erosion
Principal Investigator: Mr. Peter Lelecas
Institution: Holles Laboratories, Inc.
City / State: Cohasset, MA



Title: Topical Mustard Treatment of Mycosis Fungoides Phase II
Principal Investigator: Dr. Stuart Lessin
Institution: Fox Chase Cancer Center
City / State: Philadelphia, PA


Title: Treatment of Graft-vs-Host Disease Using Enbrel
Principal Investigator: John Levine
Institution: University of Michigan
City / State: Ann Arbor, MI


Title: Ketoralac in Surgical Infants: Pharmacokinetics/Analgesia
Principal Investigator: Dr. Anne Lynn
Institution: Children's Hospital and Regional Medical Center
City / State: Seattle, WA


Title: A Controlled Study of Olanzapine in Children with Autism
Principal Investigator: Dr. Richard Malone
Institution: MCP Hahnemann University
City / State: Philadelphia, PA


Title: Dose Study of Thymus Transplantation
Principal Investigator: Dr. Louise Markert
Institution: Duke University
City / State: Durham, NC


Title: Response of Phenylketonuria to Tetrahydrobiopterin (BH4)
Principal Investigator: Dr. Reuben Matalon
Institution: University of Texas Medical Branch
City / State: Galveston, TX


Title: PTC124 as a Therapy for Nonsense-Mutation-Mediated CF
Principal Investigator: Dr. Langdon Miller
Institution: PTC Therapeutic Inc
City / State: South Plainfield, NJ


Title: Phase II Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated DMD
Principal Investigator: Dr. Langdon Miller
Institution: PTC Therapeutics
City / State: South Plainfield, NJ



Title: Inhaled Aztreonam for Cystic Fibrosis
Principal Investigator: Dr. Alan Bruce Montgomery
Institution: Corus Pharma, Inc
City / State: Seattle, WA


Title: Effect of Lorenzo's Oil (LO) in men with AMN phenotype of X-ALD and Symptomatc
Carrier Women
Principal Investigator: Dr. Hugo Moser
Institution: Kennedy Krieger Research Institute, inc.
City / State: Baltimore, MD


Title: Intraperitoneal Floxuridine in Gastric Carcinoma
Principal Investigator: Dr. Franco Muggia
Institution: New York University School of Medicine
City / State: New York, NY


Title: Dextromethorphan in Rett Syndrome
Principal Investigator: Dr. SakkuBai Naidu
Institution: Kennedy Krieger Research Institute, Inc.
City / State: Baltimore, MD


Title: L-glutamine Therapy in Sickle Cell Anemia
Principal Investigator: Dr. Yutaka Niihara
Institution: Harbor-UCLA Research and Education Institute
City / State: Torrence, CA


Title: Phase II Study of Recombinant Human C1 Inhibitor for Treatment Angioedema
Principal Investigator: Dr. Jan Nuijens
Institution: Pharming Technologies, B.V.
City / State: Leiden, Nethelands,


Title: Phase I Trial of Y-DOTA-ryr-Octreotide in Children with Somatostatin Receptor Positive
Tumors
Principal Investigator: Dr. Sue O'Dorisio
Institution: The University of Iowa
City / State: Iowa City, IA


Title: Phase I Study of Pirfenidone in Children with PNs in NF1
Principal Investigator: Dr. Roger Packer
Institution: Children's Research Institute
City / State: Washington, DC



Title: Restoration of Hand-Arm Function with Neuroprostheses
Principal Investigator: Dr. Paul Peckham
Institution: Case Western Reserve University
City / State: Cleveland, OH


Title: Erythropoiesis & Pulse Arginine Butyrate in Sickle Cell Disease
Principal Investigator: Susan Perrine
Institution: Boston University School of Medicine
City / State: Boston, MA


Title: Triostat in Children During CPB
Principal Investigator: Dr. Michael Portman
Institution: Children's Hospital and Regional Medical Center
City / State: Seattle, WA


Title: Calcitriol & Dexamethasone for Myelodysplastic Syndromes
Principal Investigator: Dr. Robert Redner
Institution: University of Pittsburgh
City / State: Pittsburgh, PA


Title: Defibrotide for the Treatment of Severe Hepatic Veno-occlusive Disease
Principal Investigator: Dr. Paul Richardson
Institution: Dana-Farber Cancer Institute
City / State: Boston, MA


Title: Clotrimazole Enemas for Pouchitis in Children and Adults
Principal Investigator: Dr. Paul Rufo
Institution: Children's Hospital
City / State: Boston, MA


Title: Vasoactive Intestinal Peptide in the Acute Respiratory Distress Syndrome
Principal Investigator: Dr. Sami Said
Institution: SUNY at Stony Brook
City / State: Stony Brook, NY


Title: Imuran Dose Ranging Study in Crohn's Disease
Principal Investigator: Bruce Sands
Institution: Massachusetts General Hospital
City / State: Boston, MA



Title: Losartan vs. Atenolol for the Treatment of Marfan Syndrome
Principal Investigator: Dr. Lynn Sleeper
Institution:
City / State: Watertown, MA


Title: Enalapril Maleate in the Treatment of Ventricular Dysfunction in Infants with Functional
Single Ventricle
Principal Investigator: Dr. Lynn Sleeper
Institution: New England Research Institutes
City / State: Watertown, MA


Title: Treatment of Advanced Pancreatic Cancer with Opioid Growth Factor: Phase II
Principal Investigator: Dr. Jill Smith
Institution: Pennsylvania State University
City / State: Hershey, PA


Title: Oxandrolone for the Treatment of Marrow Aplasia in Fanconi Anemia
Principal Investigator: Dr. Franklin Smith
Institution: Children's Hospital Medical Center
City / State: Cincinnati, OH


Title: Inhibition of NF-kB Signaling in Melanoma Therapy
Principal Investigator: Dr. Jeffrey Sosman
Institution: Vanderbilt University Medical School
Vanderbilt Unversity Medical School
City / State: Nashville, TN


Title: Phase 3 Trial of Coenzyme Q10 in Mitochondrial Diseases
Principal Investigator: Dr. Peter Stacpoole
Institution: University of Florida
City / State: Gainesville, FL


Title: Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia
Principal Investigator: Dr. Karen Swanson
Institution: Mayo Clinic Rochester
City / State: Rochester, MN


Title: Terlipressin in Hepatorenal Syndrome (HRS) Type 1
Principal Investigator: Dr. Peter Teuber
Institution: Orphan Therapeutics, LLC
City / State: Lebanon, NJ



Title: Implantable Functional Neuromuscular Stimulation (FNS) System for Standing
Principal Investigator: Dr. Ronald Triolo
Institution: Case Western Reserve University
City / State: Cleveland, OH


Title: Phase 2 Trial: Talabostat in Chronic Lymphocytic Leukemia
Principal Investigator: Dr. Margaret Uprichard
Institution: Point Therapeutics, Inc
City / State: Boston, MA


Title: Inhaled NO Pediatric Painful Sickle Crisis
Principal Investigator: Dr. Debra Weiner
Institution: Children's Hospital Boston
City / State: Boston, MA


Title: Phase 2 Trial of Recombinant Human Prolactin for Lactation Induction
Principal Investigator: Dr. Corrine Welt
Institution: Massachusetts General Hospital
City / State: Boston, MA


Title: Trial of Alendronate Disodium in Pediatric Gaucher Disease
Principal Investigator: Dr. Richard Wenstrup
Institution: Children's Hospital Medical Center
City / State: Cincinnati, OH


Title: MIBG plus Intensive Chemotherapy for Neuroblastoma
Principal Investigator: Gregory Yanik
Institution: University of Michigan Cancer Center
City / State: Ann Arbor, MI


Title: Fondaparinux in Children with Thrombosis
Principal Investigator: Dr. Guy Young
Institution: Children's Hospital of Orange County
City / State: Orange, CA


Title: Immune Monitor for COG Trial of Anti-GD2 in Neuroblastoma
Principal Investigator: Alice Yu
Institution: University of California - San Diego
City / State: La Jolla, CA

horizontal rule